Gladys Alonso
General Practice · Hialeah, FLNPI 1306953641
Payments from drug & device makers
Across 173 payments — averaging $39.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$829
- Radius Health, Inc.$741
- Amgen$349
- Amarin Pharma, Inc.$295
- Lilly USA, LLC$278
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,68998%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,908 |
| GSK | 23 | $829 |
| Radius Health, Inc. | 21 | $741 |
| Amgen | 5 | $349 |
| Amarin Pharma, Inc. | 6 | $295 |
| Lilly USA, LLC | 11 | $278 |
| Esperion Therapeutics, Inc. | 2 | $259 |
| Sanofi-aventis U.S. LLC | 3 | $237 |
| Kowa Pharmaceuticals America, Inc. | 13 | $235 |
| Novartis | 2 | $235 |
| Novo Nordisk | 4 | $229 |
| AstraZeneca | 4 | $206 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $147 |
| Boehringer Ingelheim | 5 | $130 |
| Edwards Lifesciences | 1 | $125 |
| Abbott | 2 | $122 |
| Sunovion Pharmaceuticals Inc. | 1 | $121 |
| Merck | 1 | $112 |
| Johnson & Johnson | 1 | $107 |
| Astellas Pharma US Inc | 3 | $44 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Medicure Pharma Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tymlos$464
- VRAYLAR$375
- Creon$370
- TRELEGY ELLIPTA$356
- NEXLIZET$259
- NEXLETOL$259
- Prolia$248
- ENTRESTO$235
- Edwards SAPIEN 3 Transcatheter Heart Valve$125
- LINZESS$124
- LONHALA MAGNAIR$121
- STEGLATRO$112
- FARXIGA$112
- XARELTO$107
- Vascepa$106
How this compares
$6,799 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 23 | $22,073 |
| JanuviaSitagliptin Phosphate | 19 | $11,156 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,207 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,025 |
| HumalogInsulin Lispro | 11 | $3,679 |
| LantusInsulin Glargine,hum.Rec.Anlog | 24 | $3,603 |
| Pitavastatin Calcium | 16 | $1,601 |
| Trifluoperazine Hcl | 40 | $988 |
| Diclofenac Sodium | 43 | $924 |
| Omeprazole | 102 | $917 |
| SsdSilver Sulfadiazine | 13 | $504 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $500 |
| Memantine Hcl | 16 | $434 |
| Metoprolol Succinate | 50 | $392 |
| Gabapentin | 32 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $112 | $11,15619 claims |
| GSKAnoro Ellipta | $829 | $5,20711 claims |
| Lilly USA, LLCHumalog | $278 | $3,67911 claims |
| Sanofi-aventis U.S. LLCLantus | $237 | $3,60324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Hialeah
- Frank AlvarezHialeah$13.6M
- Manuel SanchezHialeah$5.2M
- Gustavo TorresHialeah$3M
- Maria NualartHialeah$2.7M
- Agustin RivasHialeah$2M
- Heliodoro RuizHialeah$1.6M
- Idania FernandezHialeah$1.5M
- Gilda de la CalleHialeah$1.4M
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.